Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001290802 | SCV001478959 | likely pathogenic | Neurofibromatosis, type 1 | 2020-10-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002339716 | SCV002643857 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-07-16 | criteria provided, single submitter | clinical testing | The c.5266delG pathogenic mutation, located in coding exon 37 of the NF1 gene, results from a deletion of one nucleotide at nucleotide position 5266, causing a translational frameshift with a predicted alternate stop codon (p.V1756Sfs*3). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |